Patents by Inventor Drew Watson

Drew Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110039271
    Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.
    Type: Application
    Filed: October 25, 2010
    Publication date: February 17, 2011
    Inventors: WAYNE COWENS, JOFFRE B. BAKER, KIM CLARK, JAMES HACKETT, DREW WATSON, SOONMYUNG PAIK
  • Publication number: 20110039270
    Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.
    Type: Application
    Filed: October 25, 2010
    Publication date: February 17, 2011
    Inventors: Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett, Drew Watson, Soonmyung Paik
  • Publication number: 20100285980
    Abstract: Algorithm-based molecular assays that involve measurement of expression levels of prognostic and/or predictive genes, or co-expressed genes thereof, from a biological sample obtained from a cancer patient, and analysis of the measured expression levels to provide information concerning the likelihood of recurrence of colorectal cancer and/or the likelihood of a beneficial response to chemotherapy for the patient are provided herein. Methods of analysis of gene expression values of prognostic and/or predictive genes, as well as methods of identifying gene expression-tumor region ratios, tumor-associated stromal surface area, and gene cliques, i.e. genes that co-express with a validated biomarker and thus may be substituted for that biomarker in an assay, are also provided.
    Type: Application
    Filed: April 30, 2010
    Publication date: November 11, 2010
    Inventors: Steven Shak, Drew Watson, Xitong Li, Lawrence Lee, Kim Langone
  • Publication number: 20100190173
    Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.
    Type: Application
    Filed: January 29, 2010
    Publication date: July 29, 2010
    Inventors: Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett, Drew Watson, Soonmyung Paik
  • Publication number: 20100151463
    Abstract: The present disclosure provides methods for determining the HER2 Status of a cancer tumor sample.
    Type: Application
    Filed: September 4, 2009
    Publication date: June 17, 2010
    Inventors: Frederick L. Baehner, Drew Watson, Tara Maddala, Steve Shak, Robert Gray, Joseph Sparano
  • Patent number: 7695913
    Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.
    Type: Grant
    Filed: January 11, 2007
    Date of Patent: April 13, 2010
    Assignees: Genomic Health, Inc., NSABP Foundation, Inc.
    Inventors: Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett, Drew Watson, Soonmyung Paik
  • Publication number: 20090305277
    Abstract: The present invention relates to gene sets useful in assessing prognosis and/or predicting the response of cancer, e.g. colorectal cancer to chemotherapy. In addition, the invention relates to a clinically validated cancer test, e.g. colorectal test, for assessment of prognosis and/or prediction of patient response to chemotherapy, using expression analysis. The present invention accommodates the use of archived paraffin embedded biopsy material for assay of all markers in the relevant gene sets and therefore is compatible with the most widely available type of biopsy material.
    Type: Application
    Filed: March 13, 2009
    Publication date: December 10, 2009
    Inventors: Joffre B. Baker, Wayne Cowens, Kim Langone, James Hackett, Drew Watson, Soonmyung Paik
  • Publication number: 20090298701
    Abstract: The present invention provides methods and compositions to facilitate determining whether an EGFR-expressing cancer in an individual is an EGFR inhibitor-responsive cancer, as well as methods for determining the likelihood that a patient having an EGFR-expressing cancer will exhibit a beneficial response to an EGFR inhibitor therapy. The methods generally involve determining a normalized expression level of a gene product that correlates with EGFR inhibitor responsiveness.
    Type: Application
    Filed: May 13, 2009
    Publication date: December 3, 2009
    Inventors: Joffre B. Baker, Drew Watson, Tara Maddala, Steven Shak, David J. Mauro, Shirin K. Ford
  • Publication number: 20090291434
    Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.
    Type: Application
    Filed: January 11, 2007
    Publication date: November 26, 2009
    Inventors: Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett, Drew Watson, Soonmyung Paik
  • Publication number: 20090258795
    Abstract: A method of predicting clinical outcome in a subject diagnosed with cancer and treated with chemotherapy comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample comprising cancer cells obtained from the subject.
    Type: Application
    Filed: March 14, 2008
    Publication date: October 15, 2009
    Applicants: GENOMIC HEALTH, INC., NSABP FOUNDATION, INC.
    Inventors: Wayne Cowens, Joffre Baker, Kim Langone, Drew Watson, James Hackett, Soonmyung Paik
  • Patent number: 5658447
    Abstract: An electrolytic reduction cell for the production of metal is provided, in which liquid metal is deposited at or adjacent an upper surface of a cathode. The electrolytic reduction cell includes an anode structure and a cathode located beneath the anode structure, wherein an upper portion of the cathode comprises an aggregate of particles sized and shaped such that in operation of the cell liquid metal is present in at least an upper part of the aggregate and a slurry of liquid metal and particles is established, the slurry comprising a substantially uniform dispersion of the particles in a continuous liquid phase of the liquid metal, the slurry having a viscosity sufficiently high such that under operating conditions of the cell the slurry is relatively immobile. Methods for the production of a metal by electrolysis in the electrolytic cell are also provided.
    Type: Grant
    Filed: February 21, 1996
    Date of Patent: August 19, 1997
    Assignee: Comalco Aluminium Limited
    Inventors: Kevin Drew Watson, Drago Dragutin Juric, Raymond Walter Shaw, Geoffrey James Houston